MAPT and tauopathy: Whilst there is some promise for a small number of the second-generation tracers (e.g. [18F]PI-2620 and [18F]APN-1607) in identifying the presence of tau in those with PSP [7–9], a specific tracer for the 4-repeat (or 3-repeat) tauopathies remains to be developed.